HMBD-802
/ Hummingbird Biosci, Callio Therapeutics
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
October 23, 2024
Hummingbird Bioscience Announces Poster Presentation on HMBD-802, Novel Dual-Payload Antibody-Drug Conjugate, at EORTC-NCI-AACR 2024
(GlobeNewswire)
- "Hummingbird Bioscience...announced a poster presentation on HMBD-802, a novel first-in-class dual-payload anti-HER2 antibody-drug conjugate, at the 36th EORTC-NCI-AACR symposium (23-25 October 2024)."
Preclinical • Oncology
1 to 1
Of
1
Go to page
1